Skip to main content
Log in

Medication use during pregnancy and the risk of childhood cancer in the offspring

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The young age at onset of many cancers in childhood has led to investigations on maternal exposures during pregnancy. Data from a population-based case-control study in Germany (1992–1997) that included 1,867 cases and 2,057 controls was used to investigate this question. Maternal use of vitamin, folate or iron supplementation was associated with a reduced risk of non-Hodgkin lymphoma and tumors and, less clearly, with leukemia, but not with CNS tumors. An increased risk of neuroblastoma was associated most markedly with diuretics and other antihypertensives, but also with vitamin, folate or iron supplementation. No associations were seen with pain relievers, antinauseants or cold medications, nor with delivery by Caesarian section. The strengths of this study are its population base, the large number of cases and the inclusion of different case groups to identify disease specificity of associations. The limitation of this study is an exposure assessment relying on maternal self-reports. In conclusion, these data indicate a potential influence of some maternal medication during pregnancy on the risk of childhood cancer in the offspring; however, no clear picture is seen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ALL:

acute lymphoblastic leukemia

AML:

acute myeloblastic leukemia

CNS:

central nervous system

NHL:

non-Hodgkin lymphoma

OR:

odds ratio

CI:

confidence interval

SES:

socioeconomic status

References

  1. Anderson LM, Diwan BA, Fear NT, Roman E (2000) Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 108:573–594

    Article  PubMed  Google Scholar 

  2. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Munlinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A (1999) Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485–1490

    Article  PubMed  CAS  Google Scholar 

  3. Bonati M, Bortelus R, Marchetti F, Romero M, Rognoni G (1990) Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 38:325–328

    Article  PubMed  CAS  Google Scholar 

  4. Brookmeyer R, Liang KY, Linet M (1986) Matched case-control designs and overmatched analyses. Am J Epidemiol 124:693–701

    PubMed  CAS  Google Scholar 

  5. Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT (1993) Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 329:536–541

    Article  PubMed  CAS  Google Scholar 

  6. Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT (1994) Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 3:197–204

    PubMed  CAS  Google Scholar 

  7. Carozza SE, Olshan AF, Faustman EM, Gula MJ, Kolonel LN, Austin DF, West ED, Weiss NS, Swanson GM, Lyon LK, Hedley-Whyte T, Gilles FH, Aschenbrenner C, Leviton A (1995) Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumours. Int J Epidemiol 24:308–312

    Article  PubMed  CAS  Google Scholar 

  8. Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, Bondy ML, Pollock BH (2004) Maternal medication use and neuroblastoma in offspring. Am J Epidemiol 159:721–731

    Article  PubMed  Google Scholar 

  9. Feuring M, Melchert F, Wehling M (1999) Pharmacotherapy for hypertonia in pregnancy. Gynäkologe 32:443–449

    Google Scholar 

  10. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 94:13950–13954

    Article  PubMed  CAS  Google Scholar 

  11. German Childhood Cancer Registry: Annual Report 2004 (1980–2003) Technical report, Institute of Medical Biostatistics, Epidemiology and Informatics, 2005 (http://www.kinderkrebsregister.de)

  12. Greaves MF (2002) Childhood leukaemia. BMJ 324:283–287

    Article  PubMed  Google Scholar 

  13. Hjalgrim LL, Madsen HO, Melbye M, Jorgensen P, Christiansen M, Andersen P, Pallisgaat N, Hokland P, Clausen N, Ryder LP, Schmiegelow K, Hjalgrim H (2002) Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 87:994–999

    Article  PubMed  CAS  Google Scholar 

  14. Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S (2004) Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 15:559–570

    Article  PubMed  Google Scholar 

  15. Khera KS (1987) Maternal toxicity of drugs and metabolic disorders-a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data. Crit Rev Toxicol 17:345–375

    PubMed  CAS  Google Scholar 

  16. Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66–68

    Article  PubMed  CAS  Google Scholar 

  17. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823

    Article  PubMed  Google Scholar 

  18. Kramer S, Ward E, Meadows AT, Malone KE (1987) Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 78:797–804

    PubMed  CAS  Google Scholar 

  19. Law GR, Smith AG, Roman E; United Kingdom Childhood Cancer Study Investigators (2002) The importance of full participation: lessons from a national case-control study. Br J Cancer 86:350–355

    Article  PubMed  CAS  Google Scholar 

  20. Lightfoot TJ, Roman E (2004) Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 199:104–117

    Article  PubMed  CAS  Google Scholar 

  21. Little J (1999) Epidemiology of childhood cancer. IARC Scientific Publications No 149. Lyon, France

    Google Scholar 

  22. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC (1996) Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 143:996–1001

    PubMed  CAS  Google Scholar 

  23. Michaelis J, Haaf HG, Zöllner J, Kaatsch P, Krummenauer F, Berthold F (1996) Case-control study of neuroblastoma in West Germany after the Chernobyl accident. Klin Padiatr 208:172–178

    Article  PubMed  CAS  Google Scholar 

  24. Neuhäuser M, Becher H (1997) Improved odds ratio estimation by post hoc stratification of case-control data. Stat Med 16:993–1004

    Article  PubMed  Google Scholar 

  25. Olshan AF, Faustman EM (1989) Nitrosable drug exposure during pregnancy and adverse outcome. Int J Epidemiol 18:891–899

    Article  PubMed  CAS  Google Scholar 

  26. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH (2002) Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology 13:575–580

    Article  PubMed  Google Scholar 

  27. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Kouliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, Tzortzatou F (1997) The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 76:1241–1247

    PubMed  CAS  Google Scholar 

  28. Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL (1996) Maternal consumption of cured meats and vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 5:599–605

    PubMed  CAS  Google Scholar 

  29. Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Fillippini G, Cordier S, Peris-Bonet R, Choi W, Little J, Arslan A (1998) Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation. Environ Health Perspect 106:887–892

    Article  PubMed  Google Scholar 

  30. Rath W (1999) Hypertensive diseases in pregnancy. Gynäkologe 32:432–442

    Google Scholar 

  31. Robison LL, Buckley JD, Bunin G (1995) Assessment of environmental and genetic factors in the biology of childhood cancers: the Children‘s Cancer Group epidemiology program. Environ Health Perspect 6:111–116

    Article  Google Scholar 

  32. Roman E, Ansell P, Bull D (1997) Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Br J Cancer 76:406–415

    PubMed  CAS  Google Scholar 

  33. Roman E, Simpson J, Ansell P, Lightfoot T, Mitchell C, Eden TO (2005) Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer 41:749–759

    Article  PubMed  CAS  Google Scholar 

  34. Ross JA, Swensen AR (2000) Prenatal epidemiology of pediatric tumors. Curr Oncol Rep 2:234–241

    PubMed  CAS  Google Scholar 

  35. Schüz J, Kaatsch P (2002) Epidemiology of pediatric tumors of the central nervous system. Exp Rev Neurotherapeutics 2:469–480

    Article  Google Scholar 

  36. Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639

    Article  PubMed  Google Scholar 

  37. Schüz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J (2001) Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol 54:702–709

    Article  PubMed  Google Scholar 

  38. Schüz J, Spector LF, Ross JA (2003) Bias in studies of parental self-reported occupational exposures and childhood cancer. Am J Epidemiol 158:710–716

    Article  PubMed  Google Scholar 

  39. Schwartzbaum JA (1992) Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol 135:1358–1367

    PubMed  CAS  Google Scholar 

  40. Shaw AK, Infante-Rivard C, Morrison HI (2004) Use of medication during pregnancy and risk of childhood leukemia (Canada). Cancer Causes Control 15:931–937

    Article  PubMed  Google Scholar 

  41. Shu XO, Perentesis JP, Wen W, Buckley JD, Boyle E, Ross JA, Robison LL (2004) Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 13:1230–1235

    PubMed  CAS  Google Scholar 

  42. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192

    Article  PubMed  Google Scholar 

  43. Stokes ME, Davis CS, Koch GG (1995) Categorical data analysis using the SAS System. SAS Institute Inc., Cary, NC, USA

    Google Scholar 

  44. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK (2001) Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358:1935–1940

    Article  PubMed  CAS  Google Scholar 

  45. UK Childhood Cancer Study Investigators (2000). The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators. Br J Cancer 82:1073–1102

    Article  Google Scholar 

  46. Unadkat JD, Dahlin A, Vijay S (2004) Placental drug transporters. Curr Drug Metab 5:125–131

    Article  PubMed  CAS  Google Scholar 

  47. van Poppel G, van den Berg H (1997) Vitamins and cancer. Cancer Lett 114:195–202

    Article  PubMed  Google Scholar 

  48. Wen W, Shu XO, Potter JD, Severson RK, Buckley JD, Reaman GH, Robison LL (2002) Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 95:1786–1794

    Article  PubMed  Google Scholar 

  49. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354:1499–1503

    Article  PubMed  CAS  Google Scholar 

  50. Wogelius P, Poulsen S, Sorensen HT (2005) Validity of parental-reported questionnaire data on Danish children's use of asthma-drugs: a comparison with a population-based prescription database. Eur J Epidemiol 20:17–22

    Article  PubMed  Google Scholar 

  51. Yankowitz J (2004) Pharmacologic treatment of hypertensive disorders during pregnancy. J Perinat Neonat Nurs 18:230–240

    Google Scholar 

Download references

Acknowledgements

We would especially like to thank Dr. Ina Reiß for her skillful work on the data set and for the preparation of preliminary analyses. We would like to thank Monika Decher-Neff and Ilona Kerenyi for their assistance in coding the medications. We would also like to thank Drs. Rolf Meinert, Uwe Kaletsch and Jörg Michaelis for their work during the conducting of the original study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Kaatsch.

Additional information

Sponsored by the Federal Ministry for the Environment, Nuclear Safety, and Nature Protection.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schüz, J., Weihkopf, T. & Kaatsch, P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 166, 433–441 (2007). https://doi.org/10.1007/s00431-006-0401-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-006-0401-z

Keywords

Navigation